NCT05170399
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Neoplasms by Histologic Type
Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.
30,171 public trials
6,473 recruiting studies
Neoplasms by Histologic Type trial results
NCT07280715
- Conditions
- Cancer, Immunotherapy, Melanoma, +12 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT05168163
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Cleveland Clinic Weston Florida Weston, Florida, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT06245603
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Humanitas Gavezzeni-Bergamo Bergamo, Italy
- Ospedale Sant'Orsola - Malpighi Bologna, Italy
- Policlinico Ospedali Riuniti - Foggia Foggia, Italy
- Istituto Oncologico Veneto IRCCS Padova, Italy
NCT02507141
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (consent only) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (consent only) Middletown, New Jersey, United States
- Memorial Sloan Kettering West Harrison (consent only) Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT04910685
- Conditions
- Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +7 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus Aurora, Colorado, United States
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Conditions
- Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
- Locations
-
- USOR HonorHealth Phoenix, Arizona, United States
- USOR Arizona Oncology Associates Tucson, Arizona, United States
- University of California Los Angeles Medical Center Los Angeles, California, United States
- University of California, San Diego; Moores Cancer Center San Diego, California, United States
NCT06409013
- Conditions
- Bone Diseases, Bone Neoplasms, Bone Sarcoma, +7 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06801236
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
- Locations
-
- University of California San Diego, Moores Cancer Center La Jolla, California, United States
- Moffitt Cancer Center, Tampa Tampa, Florida, United States
- University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Harvard Medical School-Massachusetts General Hospital Boston, Massachusetts, United States
NCT06622941
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Complex and Mixed, +1 more
- Locations
-
- Nagoya University Hospital Nagoya, Aichi-ken, Japan
- Hokkaido University Hospital Sapporo, Hokkaido, Japan
- Hyogo Prefectural Kobe Children's Hospital Kobe, Hyōgo, Japan
- Osaka City General Hospital Osaka, Japan